|4Nov 3, 4:16 PM ET

FROM STEPHEN 4

4 · EYEGATE PHARMACEUTICALS INC · Filed Nov 3, 2020

Insider Transaction Report

Form 4
Period: 2020-11-02
FROM STEPHEN
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2020-11-02$3.51/sh623$2,18778,581 total
Footnotes (1)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 11/01/2020.

Documents

1 file
  • 4
    tm2034888d4_form4.xmlPrimary

    FORM 4